Conference · London, United Kingdom
Gene Therapy for Rare Disorders Europe
Exhibition Industry, Convention Industry
Key numbers
- Editions on record
- 1first in 2017
About Gene Therapy for Rare Disorders Europe
Gene Therapy for Rare Disorders Europe is devoted to overcoming these challenges, focusing specifically on the clinical, manufacturing, regulatory and reimbursement hurdles that need to be overcome for gene therapies to reach their full potential. Uniting leaders from Pfizer, GSK, Shire and uniQure, this meeting focusses specifically on delivering practical insights into developing the next generation of gene therapies that promise improved efficacy, enhanced safety and commercial viability. Join your colleagues at this uniquely focused event and discover how to enhance every stage of your gene therapy development to achieve commercial success. Prices do not include VAT. Email info@hansonwade.com for an Academic rate.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2017 | 31 Oct – 2 Nov 2017 | Hilton London Olympia London, United Kingdom | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Gene Therapy for Rare Disorders Europe?
The next dates haven't been confirmed. The last edition we have on record was 31 Oct – 2 Nov 2017.
Where is it held?
The last edition we have was at Hilton London Olympia, London, United Kingdom.